We are thrilled to see two brilliant papers by researchers from the Rio Tinto Children's Diabetes Cente, a Breakthrough T1D Centre of Excellence, featured in this year's esteemed Advanced Technologies & Treatments for Diabetes (ATTD) 2024 Yearbook.
Published and released last month at the 2025 ATTD international conference in Amsterdam, the 16th ATTD Yearbook summarises the most important articles in the field of diabetes technology published in medical journals during the period between July 2023 to June 2024.
Congratulations to Associate Professor Aveni Haynes and Dr Kate Lomax, who both had papers highlighted in Chapter 2, Continuous and Intermittent Glucose Monitoring in 2024. Only 13 papers were selected in this chapter from more than 4,000 internationally published articles on glucose monitoring.
The editors comments on Associate Professor Haynes' published paper 'Early Dysglycemia Is Detectable Using Continuous Glucose Monitoring in Very Young Children at Risk of Type 1 Diabetes' said the study fills a significant gap in our understanding of CGM-captured early glycemic fluctuations in children with persistent multiple islet autoimmunity, providing data that should inform future approaches to type 1 diabetes prevention and early intervention.
Dr Kate Lomax's published paper: 'Improved Glycemic Outcomes with Diabetes Technology Use Independent of Socioeconomic Status in Youth with Type 1 Diabetes', was featured twice in the Yearbook, as well as Chapter 2, it was also featured in Chapter 8 - the Diabetes Technology and Therapy in the Pediatric Age Group' chapter. Editors said the issue of barriers to accessing diabetes technology for children with type 1 diabetes remains a global concern, possibly widening disparities in glycemic outcomes. "The study has a critical insight, as it challenges the assumption that lower socioeconomic status (SES) might diminish the effectiveness of advanced diabetes management technologies."